Middle-Aged Adults Taking GLP-1s Could Cut Medical Costs
A fresh health-economics study links the use of GLP-1 obesity drugs to sizable lifetime medical cost reductions for 4...
What Does Index Level Tell You About The Market explains how the index reflects market conditions and helps you interpret momentum for decisions.
28,521 articlesA fresh health-economics study links the use of GLP-1 obesity drugs to sizable lifetime medical cost reductions for 4...
The U.S. IPO market is rekindling activity in 2026, with more offerings and steadier early trading as investors weigh...
Regulators signal a softer approach while a Trump-linked venture secures $75 million from Justin Sun, fueling specula...
Prediction markets are trending fast, with many new participants drawn to the thrill of forecasting outcomes. This gu...
Investors chase the next big AI champion. This piece breaks down how a single AI stock could grow into a trillion-dol...
A major fund’s exit from Ocular Therapeutix raises questions about timing, liquidity, and sector signals. This articl...
A leading analyst signals more upside for CVS Health as Medicare-related momentum builds. Learn the key drivers, risk...
Flotek's 2025 earnings outlook hinges on energy demand, cost control, and segment mix. This guide breaks down what to...
Pennsylvania is weighing a tax move that would extend the state's telecom gross receipts tax to digital advertising. ...
Railroads still power the economy, and the big players like Union Pacific and CSX remain compelling for long-term inv...
Two defense giants, two paths to growth. This guide breaks down Lockheed Martin and RTX, outlining which offers more ...
The eVTOL craze mixes hype with real engineering, regulatory hurdles, and capital burn. Here's why I wouldn't touch t...